194
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Factors associated with dysmenorrhoea and menorrhagia improvement in patients with adenomyosis after uterine artery embolisation

, , , , &
Article: 2372645 | Received 19 Oct 2023, Accepted 20 Jun 2024, Published online: 29 Jun 2024

References

  • Abbott, J.A., 2017. Adenomyosis and abnormal uterine bleeding (AUB-A)-pathogenesis, diagnosis, and management. Best Practice & Research. Clinical Obstetrics & Gynaecology, 40, 1–10.
  • Bae, S.H., et al., 2015. Uterine artery embolization for adenomyosis: percentage of necrosis predicts midterm clinical recurrence. Journal of Vascular and Interventional Radiology, 26 (9), 1290–1296.e2.
  • Bilhim, T., et al., 2011. Polyvinyl alcohol particle size for uterine artery embolization: a prospective randomized study of initial use of 350-500 mum particles versus initial use of 500-700 mum particles. Journal of Vascular and Interventional Radiology, 22 (1), 21–27.
  • Bratby, M.J. and Walker, W.J., 2009. Uterine artery embolisation for symptomatic adenomyosis–mid-term results. European Journal of Radiology, 70 (1), 128–132.
  • Byun, J.Y., et al., 1999. Diffuse and focal adenomyosis: MR imaging findings. Radiographics: a Review Publication of the Radiological Society of North America, Inc, 19 Spec No (suppl_1), S161–S70.
  • De Bruijn, A. M., et al., 2017a. Uterine artery embolization for symptomatic adenomyosis: 7-year clinical follow-up using UFS-Qol questionnaire. CardioVascular and Interventional Radiology, 40 (9), 1344–1350.
  • De Bruijn, A.M., et al., 2017b. Uterine artery embolization for the treatment of adenomyosis: a systematic review and meta-analysis. Journal of Vascular and Interventional Radiology, 28 (12), 1629–1642.e1.
  • De Franciscis, P., et al., 2022. Hysteroscopic and ultrasonographic evaluation of ulipristal acetate treatment for symptomatic myomas in premenopausal women: a prospective study. Minimally Invasive Therapy & Allied Technologies:: official Journal of the Society for Minimally Invasive Therapy, 31 (3), 435–440.
  • Dessouky, R., et al., 2019. Management of uterine adenomyosis: current trends and uterine artery embolization as a potential alternative to hysterectomy. Insights into Imaging, 10 (1), 48.
  • Gaia, G., et al., 2009. Menses recovery and fertility after artery embolization for PPH: a single-center retrospective observational study. European Radiology, 19 (2), 481–487.
  • Goodwin, S.C. and Walker, W.J., 1998. Uterine artery embolization for the treatment of uterine fibroids. Current Opinion in Obstetrics & Gynecology, 10 (4), 315–320.
  • Jung, D.C., et al., 2012. Prediction of early response to uterine arterial embolisation of adenomyosis: value of T2 signal intensity ratio of adenomyosis. European Radiology, 22 (9), 2044–2049.
  • Kaump, G.R. and Spies, J.B., 2013. The impact of uterine artery embolization on ovarian function. Journal of Vascular and Interventional Radiology, 24 (4), 459–467.
  • Kim, M.D., et al., 2007. Long-term results of uterine artery embolization for symptomatic adenomyosis. American Journal of Roentgenology, 188 (1), 176–181.
  • Kim, M.D., et al., 2011. Uterine artery embolization for symptomatic adenomyosis: a new technical development of the 1-2-3 protocol and predictive factors of MR imaging affecting outcomes. Journal of Vascular and Interventional Radiology, 22 (4), 497–502.
  • Lanciego, C., et al., 2012. Utero-ovarian anastomoses and their influence on uterine fibroid embolization. Journal of Vascular and Interventional Radiology, 23 (5), 595–601.
  • Lohle, P.N., et al., 2007. Uterine artery embolization for symptomatic adenomyosis with or without uterine leiomyomas with the use of calibrated tris-acryl gelatin microspheres: midterm clinical and MR imaging follow-up. Journal of Vascular and Interventional Radiology, 18 (7), 835–841.
  • Mccluggage, W.G., et al., 2000. Pathologic features of uterine leiomyomas following uterine artery embolization. International Journal of Gynecological Pathology: official Journal of the International Society of Gynecological Pathologists, 19 (4), 342–347.
  • Orsini, L.F., et al., 1984. Pelvic organs in premenarcheal girls: real-time ultrasonography. Radiology, 153 (1), 113–116.
  • Osuga, Y., Fujimoto-Okabe, H. and Hagino, A., 2017. Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study. Fertility and Sterility, 108 (4), 673–678.
  • Palomo, M.C.E., et al., 2009. P587 Amenorrhea after uterine fibroid embolization in women under age 45 and women over age 45. International Journal of Gynecology & Obstetrics, 107 (S2), S579–S580.
  • Pelage, J.P., et al., 2005. Midterm results of uterine artery embolization for symptomatic adenomyosis: initial experience. Radiology, 234 (3), 948–953.
  • Pelage, J.P., et al., 2002. Uterine artery embolization in sheep: comparison of acute effects with polyvinyl alcohol particles and calibrated microspheres. Radiology, 224 (2), 436–445.
  • Pelage, J.P., et al., 2003. Limited uterine artery embolization with tris-acryl gelatin microspheres for uterine fibroids. Journal of Vascular and Interventional Radiology:, 14 (1), 15–20.
  • Pontis, A., et al., 2016. Adenomyosis: a systematic review of medical treatment. Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology, 32 (9), 696–700.
  • Popovic, M., et al., 2011. Uterine artery embolization for the treatment of adenomyosis: a review. Journal of Vascular and Interventional Radiology, 22 (7), 901–909; quiz 909.
  • Poujade, O., et al., 2013. Uterine necrosis following pelvic arterial embolization for post-partum hemorrhage: review of the literature. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 170 (2), 309–314.
  • Reinhold, C., et al., 1999. Uterine adenomyosis: endovaginal US and MR imaging features with histopathologic correlation. Radiographics: a Review Publication of the Radiological Society of North America, Inc, 19 Spec No (suppl_1), S147–S60. Spec No,
  • Scheurig-Muenkler, C., et al., 2011. Uterine artery embolization for symptomatic fibroids: long-term changes in disease-specific symptoms and quality of life. Human Reproduction, 26 (8), 2036–2042.
  • Schrager, S., et al., 2022. Adenomyosis: diagnosis and management. American Family Physician, 105 (1), 33–38.
  • Senturk, L.M. and Imamoglu, M., 2015. Adenomyosis: what is new? Women’s Health, 11 (5), 717–724.
  • Shaaban, O.M., et al., 2015. Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial. Contraception, 92 (4), 301–307.
  • Sheikh, G.T., et al., 2020. Angiographic detection of utero-ovarian anastomosis and influence on ovarian function after uterine artery embolization. Cardiovascular and Interventional Radiology, 43 (2), 231–237.
  • Siskin, G.P., et al., 2001. Uterine artery embolization for the treatment of adenomyosis: clinical response and evaluation with MR imaging. AJR. American Journal of Roentgenology, 177 (2), 297–302.
  • Soave, I., et al., 2018. Treatment options and reproductive outcome for adenomyosis-associated infertility. Current Medical Research and Opinion, 34 (5), 839–849.
  • Stokes, L.S., , C., et al., 2010. Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomas. Journal of Vascular and Interventional Radiology, 21 (8), 1153–1163.
  • Struble, J., Reid, S. and Bedaiwy, M.A., 2016. Adenomyosis: a clinical review of a challenging gynecologic condition. Journal of Minimally Invasive Gynecology, 23 (2), 164–185.
  • Templeman, C., et al., 2008. Adenomyosis and endometriosis in the California Teachers Study. Fertility and Sterility, 90 (2), 415–424.
  • Tsui, K.H., et al., 2014. Medical treatment for adenomyosis and/or adenomyoma. Taiwanese Journal of Obstetrics & Gynecology, 53 (4), 459–465.
  • Vitale, S.G., et al., 2023. Hysteroscopic laser ablation of symptomatic uterine fibroids: insights from a prospective study. Climacteric: The Journal of the International Menopause Society, 26 (5), 497–502.
  • Vitale, S.G., et al., 2020. Hysteroscopic treatment of submucosal fibroids in perimenopausal women: when, why, and how? Climacteric: The Journal of the International Menopause Society, 23 (4), 355–359.
  • Von Elm, E., et al., 2008. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Journal of Clinical Epidemiology, 61 (4), 344–349.
  • Wang, Y., et al., 2020. Asherman syndrome in adenomyosis treated with uterine artery embolization: incidence predictive factors. La Radiologia Medica, 125 (5), 437–443.
  • Zheng, R., et al., 2018. Predisposing factors for predicting the therapeutic response of adenomyosis after uterine artery embolization: serum CA125 levels and accompanying endometriosis. Diagnostic and Interventional Radiology , 24 (6), 364–371.
  • Zhou, J., et al., 2016. Outcomes in adenomyosis treated with uterine artery embolization are associated with lesion vascularity: A long-term follow-up study of 252 cases. PLOS One, 11 (11), e0165610.